Question from Deputy Erin McGreehan - PQ 54216-26
Deputy McGreehan asked about the investment in the diagnosis, treatment, and ongoing management of polyendocrine metabolic ovarian syndrome (PMOS).
From: Communications and Public Affairs
Published: July 2026
Updated: September 2026
Documents
Summary
To ask the Minister for Health the level of investment currently being made by her Department and the HSE in the diagnosis, treatment, and ongoing management of polyendocrine metabolic ovarian syndrome (PMOS); the specific services available to women with PMOS within the public health system; whether women diagnosed with PMOS are eligible for assessment and treatment through ambulatory gynaecology clinics; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it